PMID- 37034991 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20230411 IS - 2589-0042 (Electronic) IS - 2589-0042 (Linking) VI - 26 IP - 4 DP - 2023 Apr 21 TI - Mannose-coated nanozyme for relief from chemotherapy-induced peripheral neuropathic pain. PG - 106414 LID - 10.1016/j.isci.2023.106414 [doi] LID - 106414 AB - Chemotherapy-induced peripheral neuropathic pain (CIPNP) is a progressive and disturbing peripheral neuropathy with currently no effective treatment. Aberrant production of reactive oxygen species (ROS) in macrophages near peripheral nerves plays a dominant role in CIPNP; however, traditional ROS scavengers have difficulty maintaining viability to target macrophages in vivo. Mannose-coated superparamagnetic iron oxide nanoparticles (mSPIONs) were synthesized to treat CIPNP. The anti-ROS and anti-inflammatory effects of mSPIONs were assessed in J774A.1 cells and sciatic nerves in a nociception mouse model induced with vincristine (VCR). We found that the mSPIONs significantly reduced ROS levels in vitro and in vivo. Furthermore, mSPIONs administration specifically reduced IL-6 and TNF-alpha levels in macrophages near the sciatic nerve and relieved VCR-induced peripheral neuropathic pain. Inhibition of the VCR-upregulated HIF1alpha/NF-kappaB signaling pathway may be involved in the alleviation of inflammation. These results provide a new approach for relieving CIPNP using a nanozyme. CI - (c) 2023 The Author(s). FAU - Liu, Hu AU - Liu H AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. FAU - Qing, Xin AU - Qing X AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. FAU - Peng, Lijun AU - Peng L AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. FAU - Zhang, Ding AU - Zhang D AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. FAU - Dai, Wei AU - Dai W AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. FAU - Yang, Zhilai AU - Yang Z AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. FAU - Zhang, Jiqian AU - Zhang J AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. FAU - Liu, Xuesheng AU - Liu X AD - Department of Anesthesiology, the First Affiliated Hospital of Anhui Medical University, Key Laboratory of Anesthesiology and Perioperative Medicine of Anhui Higher Education Institutes, Anhui Medical University, No. 218 Jixi Road, Hefei, Anhui Province 20032, China. LA - eng PT - Journal Article DEP - 20230317 PL - United States TA - iScience JT - iScience JID - 101724038 PMC - PMC10074233 OTO - NOTNLM OT - Immunology OT - Molecular physiology OT - Nanotechnology OT - Neuroscience COIS- The authors declare no competing interests. EDAT- 2023/04/11 06:00 MHDA- 2023/04/11 06:01 PMCR- 2023/03/17 CRDT- 2023/04/10 04:15 PHST- 2022/05/06 00:00 [received] PHST- 2023/01/04 00:00 [revised] PHST- 2023/03/13 00:00 [accepted] PHST- 2023/04/11 06:01 [medline] PHST- 2023/04/10 04:15 [entrez] PHST- 2023/04/11 06:00 [pubmed] PHST- 2023/03/17 00:00 [pmc-release] AID - S2589-0042(23)00491-1 [pii] AID - 106414 [pii] AID - 10.1016/j.isci.2023.106414 [doi] PST - epublish SO - iScience. 2023 Mar 17;26(4):106414. doi: 10.1016/j.isci.2023.106414. eCollection 2023 Apr 21.